Total Payments
$1,638
2024 Payments
$1,517
Companies
21
Transactions
45
Payment Breakdown by Category
Food & Beverage$1,638 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,638 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $273.83 | 6 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $242.19 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $175.14 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $167.84 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $143.71 | 2 | $0 (2024) |
| Amgen Inc. | $137.69 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $133.97 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $76.69 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $49.40 | 2 | $0 (2024) |
| PharmaEssentia USA Corporation | $34.61 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,517 | 39 | AstraZeneca Pharmaceuticals LP ($273.83) |
| 2023 | $120.74 | 6 | Novartis Pharmaceuticals Corporation ($76.58) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: HORMONE THERAPY | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Oncology | ||||||
| 11/19/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.32 | General |
| 10/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Bone Health | ||||||
| 09/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.52 | General |
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Oncology | ||||||
| 07/31/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Oncology | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.35 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $46.54 | General |
| Category: Oncology | ||||||
| 05/09/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Oncology | ||||||
| 04/27/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 04/23/2024 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Oncology | ||||||
| 04/16/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $32.98 | General |
About Amy Smith, NP
Amy Smith, NP is a Primary Care healthcare provider based in Laramie, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2024. The National Provider Identifier (NPI) number assigned to this provider is 1841060852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Smith, NP has received a total of $1,638 in payments from pharmaceutical and medical device companies, with $1,517 received in 2024. These payments were reported across 45 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,638).
Ad
Practice Information
- Specialty Primary Care
- Location Laramie, WY
- Active Since 01/02/2024
- Last Updated 01/02/2024
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1841060852
Products in Payments
- MYRISK (Device) $242.19
- OJJAARA (Drug) $143.71
- Padcev (Drug) $133.97
- ERLEADA (Drug) $130.00
- CALQUENCE (Drug) $125.00
- LUMAKRAS (Drug) $125.00
- KEYTRUDA (Biological) $76.69
- PIQRAY (Drug) $65.63
- SCEMBLIX (Drug) $49.29
- IMFINZI (Biological) $46.54
- BESREMI (Drug) $34.61
- OPDUALAG (Drug) $33.05
- KISQALI (Drug) $32.05
- MONJUVI (Drug) $28.79
- PLUVICTO (Drug) $28.17
- Nubeqa (Drug) $26.86
- PYLARIFY (Drug) $24.55
- DOPTELET (Drug) $24.20
- DARZALEX (Biological) $22.15
- LOQTORZI (Biological) $18.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.